New cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella. (Q34528910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

title

New cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

0 references

1 reference

(2S,8S,15S,22S,25S,26R)-8,15-dibenzyl-10,17,24-trihydroxy-22-isopropyl-26-methyl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,18,21(29),23-octaen-7-one

1 reference

inferred from

reverse claim

(2S,8S,15S,22R,25S,26R)-8,15-dibenzyl-26-methyl-22-propan-2-yl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptazapentacyclo[23.2.1.111,14.118,21.02,6]triaconta-1(28),11,14(30),18,21(29)-pentaene-7,10,17,24-tetrone

1 reference

inferred from

reverse claim

(1S,4R,5S,8R,15S,18R,19S,22R)-4,18-dimethyl-8,22-bis(2-methylpropyl)-3,17-dioxa-10,24,30,31-tetrathia-7,14,21,28,33,34,35,36-octazahexacyclo[13.13.4.12,5.19,12.116,19.123,26]hexatriaconta-2(36),9(35),11,16(34),23(33),25-hexaene-6,13,20,27-tetrone

1 reference

1 reference

(2S,8S,15S,18R,22S,25S,26R)-8,15-dibenzyl-26-methyl-22-propan-2-yl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptazapentacyclo[23.2.1.111,14.118,21.02,6]triaconta-1(28),11,14(30),21(29)-tetraene-7,10,17,24-tetrone

1 reference

1 reference

1 reference

(2S,8S,15S,18S,22R,25S,26R)-8,15-dibenzyl-26-methyl-22-propan-2-yl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptazapentacyclo[23.2.1.111,14.118,21.02,6]triaconta-1(28),11,14(30),21(29)-tetraene-7,10,17,24-tetrone

1 reference

inferred from

reverse claim

HZUISCIYFHWTKA-RKQMLEEXSA-N

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

author name string

C J Hawkins

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

M F Lavin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

E J McCaffrey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

D L Parry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

A L van den Brenk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

D J Watters

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medicinal Chemistry

4 October 2019

language of work or name

English

0 references

publication date

June 1989

1 reference

16 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

page(s)

1349-1354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

Identifiers

DOI

10.1021/JM00126A034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2724305%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

1 reference